The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Cytarabine 20 mg/ml Solution for Injection or Infusion



Pfizer Healthcare IrelandPA0822/200/001

Main Information

Trade NameCytarabine 20 mg/ml Solution for Injection or Infusion
Active SubstancesCytarabine
Dosage FormSolution for injection/infusion
Licence HolderPfizer Healthcare Ireland
Licence NumberPA0822/200/001

Group Information

ATC CodeL01BC Pyrimidine analogues
L01BC01 cytarabine

Status

License statusAuthorised
Licence Issued20/11/1989
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (see Summary of Product Characteristics, section 4.2).
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back